These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 8053858)

  • 1. Screening for bowel cancer by faecal occult blood testing.
    Jackson CL
    Aust Fam Physician; 1994 Jun; 23(6):997, 999. PubMed ID: 8053858
    [No Abstract]   [Full Text] [Related]  

  • 2. Limitations of the faecal occult blood test in screening for colorectal cancer.
    Delcò F; Sonnenberg A
    Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):119-26. PubMed ID: 10363196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for colorectal cancer using faecal blood testing: varying the positive cut-off value.
    Edwards JB
    Pathology; 2005 Dec; 37(6):565-8. PubMed ID: 16373240
    [No Abstract]   [Full Text] [Related]  

  • 4. Gastric cancer after positive screening faecal occult blood testing and negative assessment.
    Zappa M; Visioli CB; Ciatto S; Grazzini G; Rubeca T; Bonanomi AG; Confortini M; Paci E; Castiglione G
    Dig Liver Dis; 2007 Apr; 39(4):321-6. PubMed ID: 17314076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is it reasonable to use faecal occult blood test for colorectal cancer screening?
    Musil D; Tillich J
    Acta Univ Palacki Olomuc Fac Med; 1999; 142():119-21. PubMed ID: 10743740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fecal-occult-blood test screening for colorectal cancer.
    Zacks M
    J Fam Pract; 1997 Mar; 44(3):247-8. PubMed ID: 9071239
    [No Abstract]   [Full Text] [Related]  

  • 7. [Arguments against implementing a population-based screening programme for colorectal cancer].
    Bonneux L
    Ned Tijdschr Geneeskd; 2008 Aug; 152(32):1777. PubMed ID: 18754310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Colorectal cancer screening: immunological test for faecal occult blood preferred].
    Jansen JB; van Rossum LG; Laheij RJ
    Ned Tijdschr Geneeskd; 2009; 153():A474. PubMed ID: 19785842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colorectal cancer screening.
    Cher DJ
    J Public Health Med; 1993 Jun; 15(2):211-2. PubMed ID: 8353013
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of fecal occult-blood testing.
    Bond JH; Mandel JS; Church TR
    N Engl J Med; 1998 Sep; 339(11):774-5. PubMed ID: 9742033
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of fecal occult-blood screening on the incidence of colorectal cancer.
    Ransohoff DF; Pignone M
    N Engl J Med; 2001 Mar; 344(13):1022-3. PubMed ID: 11280325
    [No Abstract]   [Full Text] [Related]  

  • 12. Testing for faecal calprotectin (PhiCal) in the Norwegian Colorectal Cancer Prevention trial on flexible sigmoidoscopy screening: comparison with an immunochemical test for occult blood (FlexSure OBT).
    Hoff G; Grotmol T; Thiis-Evensen E; Bretthauer M; Gondal G; Vatn MH
    Gut; 2004 Sep; 53(9):1329-33. PubMed ID: 15306594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colorectal cancer screening using immunochemical faecal occult blood testing in Japan.
    Saito H
    J Med Screen; 2006; 13 Suppl 1():S6-7. PubMed ID: 17227634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Colorectal cancer screening is profitable].
    Pikkarainen P
    Duodecim; 1999; 115(17):1813-4. PubMed ID: 11941648
    [No Abstract]   [Full Text] [Related]  

  • 15. Screening for colorectal cancer in Europe.
    Keighley MR
    Scand J Gastroenterol; 2004 Sep; 39(9):805-6. PubMed ID: 15513376
    [No Abstract]   [Full Text] [Related]  

  • 16. Fast track referrals for colorectal cancer: the impact of the faecal occult blood test screening programme.
    Ward N; Wright J; Marsh S; Norton J
    Colorectal Dis; 2007 Mar; 9(3):258-61. PubMed ID: 17298625
    [No Abstract]   [Full Text] [Related]  

  • 17. Sensitivity of diagnostic examinations for colorectal polyps.
    Menardo G
    Tech Coloproctol; 2004 Dec; 8 Suppl 2():s273-5. PubMed ID: 15666105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recommendations on population screening for colorectal cancer in New Zealand. Members of the National Health Committee Working Party on Population Screening for Colorectal Cancer.
    N Z Med J; 1999 Jan; 112(1080):4-6. PubMed ID: 10073156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
    Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
    J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New criteria for detecting occult hemorrhage in screening for colorectal cancer].
    Ottó S
    Orv Hetil; 2001 Jul; 142(29):1541-5. PubMed ID: 11494745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.